FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597332913> ?p ?o ?g. }

• W2597332913 endingPage "3060" @default.
• W2597332913 startingPage "3055" @default.
• W2597332913 abstract "Triple-negative breast cancer is a highly aggressive type of mammalian carcinoma. It is defined by a rather weak expression of estrogen-, progesterone- and Her2-receptor, and is thus difficult to treat, resulting in low disease-free and overall survival rates of the affected patients. Hence it is important to find new therapeutic options. To this aim we analysed the incidence of some molecules from different signal transduction cascades by immunohistochemistry, which are known to correlate with triple-negative breast cancer, and correlated the expression of these molecules to different tumour traits, such as size, grading, menopausal stage, histology, lymph node affection, remote metastasis formation, and to the incidence of local and lymph node recurrence and metastasis by statistical analysis. Statistically significant correlations were found for a number of tumour characteristics and signalling molecules: HIF1α is correlated to tumour grading, β-catenin to the menopausal state of the patient, and for Notch1 a relation to lymph node affection is seen. In terms of different recurrences, a correlation of β-catenin to metastasis formation and lymph node affection could be shown, as well as coherences between XBP1 and lymph node recurrence, Notch1 and metastasis formation and FOXP3 and the occurrence of local recurrence. The presented results are in accordance with formerly published studies and therefore might comprise opportunities to develop new therapeutical strategies, which could help to handle this aggressive form of breast cancer in a manner, by which side effects would be reduced and therapeutical efficiency is increased." @default.
• W2597332913 created "2017-03-23" @default.
• W2597332913 creator A5028316313 @default.
• W2597332913 creator A5029393127 @default.
• W2597332913 creator A5050124544 @default.
• W2597332913 creator A5056412323 @default.
• W2597332913 creator A5066987584 @default.
• W2597332913 date "2017-03-16" @default.
• W2597332913 modified "2023-09-29" @default.
• W2597332913 title "Triple-negative breast cancer: New therapeutic options via signalling transduction cascades" @default.
• W2597332913 cites W1608726418 @default.
• W2597332913 cites W1966201413 @default.
• W2597332913 cites W1983953368 @default.
• W2597332913 cites W1988548899 @default.
• W2597332913 cites W2004262765 @default.
• W2597332913 cites W2004946118 @default.
• W2597332913 cites W2045909049 @default.
• W2597332913 cites W2069843021 @default.
• W2597332913 cites W2070480410 @default.
• W2597332913 cites W2071886315 @default.
• W2597332913 cites W2072764794 @default.
• W2597332913 cites W2077427232 @default.
• W2597332913 cites W2078461309 @default.
• W2597332913 cites W2085533220 @default.
• W2597332913 cites W2087281324 @default.
• W2597332913 cites W2099873362 @default.
• W2597332913 cites W2104638648 @default.
• W2597332913 cites W2111429259 @default.
• W2597332913 cites W2116760308 @default.
• W2597332913 cites W2118605519 @default.
• W2597332913 cites W2122574381 @default.
• W2597332913 cites W2123275987 @default.
• W2597332913 cites W2124112127 @default.
• W2597332913 cites W2125715291 @default.
• W2597332913 cites W2136655134 @default.
• W2597332913 cites W2143336748 @default.
• W2597332913 cites W2145805608 @default.
• W2597332913 cites W2146040378 @default.
• W2597332913 cites W2152979067 @default.
• W2597332913 cites W2158146964 @default.
• W2597332913 cites W2159711144 @default.
• W2597332913 cites W2296347968 @default.
• W2597332913 cites W2418274023 @default.
• W2597332913 cites W2547920589 @default.
• W2597332913 doi "https://doi.org/10.3892/or.2017.5512" @default.
• W2597332913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28440460" @default.
• W2597332913 hasPublicationYear "2017" @default.
• W2597332913 type Work @default.
• W2597332913 sameAs 2597332913 @default.
• W2597332913 citedByCount "8" @default.
• W2597332913 countsByYear W25973329132018 @default.
• W2597332913 countsByYear W25973329132019 @default.
• W2597332913 countsByYear W25973329132020 @default.
• W2597332913 countsByYear W25973329132021 @default.
• W2597332913 countsByYear W25973329132023 @default.
• W2597332913 crossrefType "journal-article" @default.
• W2597332913 hasAuthorship W2597332913A5028316313 @default.
• W2597332913 hasAuthorship W2597332913A5029393127 @default.
• W2597332913 hasAuthorship W2597332913A5050124544 @default.
• W2597332913 hasAuthorship W2597332913A5056412323 @default.
• W2597332913 hasAuthorship W2597332913A5066987584 @default.
• W2597332913 hasBestOaLocation W25973329131 @default.
• W2597332913 hasConcept C121608353 @default.
• W2597332913 hasConcept C126322002 @default.
• W2597332913 hasConcept C142724271 @default.
• W2597332913 hasConcept C143998085 @default.
• W2597332913 hasConcept C18903297 @default.
• W2597332913 hasConcept C204232928 @default.
• W2597332913 hasConcept C2777286243 @default.
• W2597332913 hasConcept C2779013556 @default.
• W2597332913 hasConcept C2780110267 @default.
• W2597332913 hasConcept C2780849966 @default.
• W2597332913 hasConcept C2781018059 @default.
• W2597332913 hasConcept C29537977 @default.
• W2597332913 hasConcept C3018521938 @default.
• W2597332913 hasConcept C502942594 @default.
• W2597332913 hasConcept C530470458 @default.
• W2597332913 hasConcept C71924100 @default.
• W2597332913 hasConcept C86803240 @default.
• W2597332913 hasConceptScore W2597332913C121608353 @default.
• W2597332913 hasConceptScore W2597332913C126322002 @default.
• W2597332913 hasConceptScore W2597332913C142724271 @default.
• W2597332913 hasConceptScore W2597332913C143998085 @default.
• W2597332913 hasConceptScore W2597332913C18903297 @default.
• W2597332913 hasConceptScore W2597332913C204232928 @default.
• W2597332913 hasConceptScore W2597332913C2777286243 @default.
• W2597332913 hasConceptScore W2597332913C2779013556 @default.
• W2597332913 hasConceptScore W2597332913C2780110267 @default.
• W2597332913 hasConceptScore W2597332913C2780849966 @default.
• W2597332913 hasConceptScore W2597332913C2781018059 @default.
• W2597332913 hasConceptScore W2597332913C29537977 @default.
• W2597332913 hasConceptScore W2597332913C3018521938 @default.
• W2597332913 hasConceptScore W2597332913C502942594 @default.
• W2597332913 hasConceptScore W2597332913C530470458 @default.
• W2597332913 hasConceptScore W2597332913C71924100 @default.
• W2597332913 hasConceptScore W2597332913C86803240 @default.
• W2597332913 hasIssue "5" @default.
• W2597332913 hasLocation W25973329131 @default.

• next